Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship

Despite their common use as an empirical combination therapy for the better part of a decade, there has been a recent association between combination therapy with vancomycin and piperacillin-tazobactam and high rates of acute kidney injury (AKI). The reasons for this increased association are unclea...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Karino, Shigehiko, Kaye, Keith S., Navalkele, Bhagyashri, Nishan, Bakht, Salim, Madiha, Solanki, Shantanu, Pervaiz, Amina, Tashtoush, Nader, Shaikh, Hamadullah, Koppula, Sunitha, Martin, Emily T., Mynatt, Ryan P., Murray, Kyle P., Rybak, Michael J., Pogue, Jason M.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2016
Témata:
Clinical Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879358/
https://ncbi.nlm.nih.gov/pubmed/27067325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03011-15
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky